Works matching DE "CHRONIC myeloid leukemia"
Results: 5000
Penile juvenile xanthogranuloma and neurofibromatosis type-1: risk association with juvenile myelomonocytic leukaemia?
- Published in:
- 2010
- By:
- Publication type:
- Case Study
EUTOS Score Validated for Predicting Treatment Outcomes With TKI Therapy.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 8, p. 814
- Publication type:
- Article
First-Line Treatment for Patients With CML in Chronic Phase: Second-Generation TKIs Are the Therapy of Choice.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 8, p. 781
- By:
- Publication type:
- Article
First-Line Treatment for Patients With CML in Chronic Phase: Why Imatinib Is an Appropriate Choice.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 8, p. 780
- By:
- Publication type:
- Article
Front-Line TKI Therapy for Chronic-Phase CML: the Luxury of Choice.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Which TKI Should Be Recommended as Initial Treatment for CML in Chronic Phase?
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Is Imatinib Still an Acceptable First-Line Treatment for CML in Chronic Phase?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 901
- By:
- Publication type:
- Article
Test Your Image IQ.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 9, p. 819
- Publication type:
- Article
ASCO REPORTS: HIGHLIGHTS FROM EXCLUSIVE ONCOLOGY INTERVIEWS.
- Published in:
- 2012
- Publication type:
- Interview
Advances in Genetics and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders.
- Published in:
- 2009
- Publication type:
- Abstract
When Imatinib Fails.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 4, p. 448
- By:
- Publication type:
- Article
Second-Generation TKIs in Chronic Myelogenous Leukemia.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 4, p. 446
- By:
- Publication type:
- Article
Refractory CML: Not All Forms of Resistance Are Equal.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 4, p. 437
- By:
- Publication type:
- Article
Management of Patients With Resistant or Refractory Chronic Myelogenous Leukemia.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 4, p. 430
- By:
- Publication type:
- Article
Imatinib Halts Progression to Advanced Stages of Ph-Positive Chronic Myeloid Leukemia in 6th Year of Treatment.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 1, p. 81
- Publication type:
- Article
Chronic Myeloid Leukemia: Changing the Treatment Paradigms.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1850
- By:
- Publication type:
- Article
The Savona/Talpaz Article Reviewed.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 7, p. 719
- By:
- Publication type:
- Article
The Savona/Talpaz Article Reviewed.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 7, p. 712
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia: Changing the Treatment Paradigms.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 7, p. 707
- By:
- Publication type:
- Article
Chemotherapy-induced pyoderma gangrenosum.
- Published in:
- World Council of Enterostomal Therapists Journal, 2019, v. 39, n. 1, p. 9, doi. 10.33235/wcet.39.1.9-17
- By:
- Publication type:
- Article
Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
DRESS syndrome induced by imatinib.
- Published in:
- Journal of Postgraduate Medicine, 2021, v. 67, n. 3, p. 158, doi. 10.4103/jpgm.JPGM_746_20
- By:
- Publication type:
- Article
Development of chronic myelogenous leukemia in a case of chronic lymphocytic leukemia with Tp53 gene deletion.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Is b3a2 a better prognostic variant in childhood chronic myeloid leukemia?
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Regenmessung im Mobilfunknetz: Opportunistische Erfassung meteorologischer Größen.
- Published in:
- Physik in Unserer Zeit, 2021, v. 52, n. 2, p. 88, doi. 10.1002/piuz.202001602
- By:
- Publication type:
- Article
ATRA promotes alpha tocopherol succinate-induced apoptosis in freshly isolated leukemic cells from chronic myeloid leukemic patients.
- Published in:
- Molecular & Cellular Biochemistry, 2008, v. 307, n. 1/2, p. 109
- By:
- Publication type:
- Article
Identification of common inhibitors of wild-type and T315I mutant of BCR-ABL through the parallel structure-based virtual screening.
- Published in:
- Journal of Computer-Aided Molecular Design, 2012, v. 26, n. 8, p. 983, doi. 10.1007/s10822-012-9593-7
- By:
- Publication type:
- Article
The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias.
- Published in:
- International Journal of Clinical Oncology, 2007, v. 12, n. 5, p. 327, doi. 10.1007/s10147-007-0699-1
- By:
- Publication type:
- Article
Treatment of chronic myeloid leukemia with imatinib mesylate.
- Published in:
- International Journal of Clinical Oncology, 2006, v. 11, n. 3, p. 176, doi. 10.1007/s10147-006-0582-5
- By:
- Publication type:
- Article
Stage IVB uterine endometrial cancer successfully salvaged bychemoradiotherapy and surgery.
- Published in:
- International Journal of Clinical Oncology, 2003, v. 8, n. 1, p. 60, doi. 10.1007/s101470300010
- By:
- Publication type:
- Article
Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer.
- Published in:
- International Journal of Clinical Oncology, 2003, v. 8, n. 1, p. 56, doi. 10.1007/s101470300009
- By:
- Publication type:
- Article
Shoulder pain: a hematologist's perspective.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Sustained dasatinib treatment prevents early fibrotic changes following ocular trauma.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 5, p. 1103, doi. 10.1007/s00417-020-05037-4
- By:
- Publication type:
- Article
Imatinib pharmacokinetics and creatine kinase levels in chronic myeloid leukemia patients: implications for therapeutic response and monitoring.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 7, p. 1061, doi. 10.1007/s00228-024-03675-9
- By:
- Publication type:
- Article
Role of ADME gene polymorphisms on imatinib disposition: results from a population pharmacokinetic study in chronic myeloid leukaemia.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 8, p. 1321, doi. 10.1007/s00228-022-03345-8
- By:
- Publication type:
- Article
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 9, p. 1213, doi. 10.1007/s00228-020-02910-3
- By:
- Publication type:
- Article
Feasibility of and patients' perspective on nilotinib dried blood spot self-sampling.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 6, p. 825, doi. 10.1007/s00228-019-02640-1
- By:
- Publication type:
- Article
A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 719, doi. 10.1007/s00228-016-2038-9
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 2, p. 185, doi. 10.1007/s00228-015-1968-y
- By:
- Publication type:
- Article
Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 4, p. 813, doi. 10.1007/s00228-012-1385-4
- By:
- Publication type:
- Article
Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.
- Published in:
- Nature, 2015, v. 525, n. 7569, p. 380, doi. 10.1038/nature15248
- By:
- Publication type:
- Article
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation.
- Published in:
- Nature, 2015, v. 519, n. 7541, p. 102, doi. 10.1038/nature14119
- By:
- Publication type:
- Article
Genetics: Written in blood.
- Published in:
- Nature, 2013, v. 498, n. 7455, p. S4, doi. 10.1038/498S4a
- By:
- Publication type:
- Article
A continuum model for tumour suppression.
- Published in:
- Nature, 2011, v. 476, n. 7359, p. 163, doi. 10.1038/nature10275
- By:
- Publication type:
- Article
Chemical Constituents of Cordyceps neovolkiana DL0004.
- Published in:
- Chemistry of Natural Compounds, 2021, v. 57, n. 2, p. 392, doi. 10.1007/s10600-021-03369-z
- By:
- Publication type:
- Article
A new sesquiterpene lactone from Hosta ensata.
- Published in:
- Chemistry of Natural Compounds, 2012, v. 48, n. 4, p. 580, doi. 10.1007/s10600-012-0316-z
- By:
- Publication type:
- Article
Design, in silico Evaluation, and Determination of Antitumor Activity of Potential Inhibitors Against Protein Kinases: Application to BCR-ABL Tyrosine Kinase.
- Published in:
- Biochemistry (00062979), 2024, v. 89, n. 6, p. 1094, doi. 10.1134/S0006297924060099
- By:
- Publication type:
- Article
T315I – a gatekeeper point mutation and its impact on the prognosis of chronic myeloid leukemia.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2024, v. 5, n. 4, p. 412, doi. 10.1515/almed-2024-0069
- By:
- Publication type:
- Article
A short review about chronic myeloid leukemia.
- Published in:
- Journal of Life & Bio-Sciences Research (JLBSR), 2023, v. 4, n. 1, p. 15, doi. 10.38094/jlbsr40172
- By:
- Publication type:
- Article